WallStSmart

Keysight Technologies Inc (KEYS)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Keysight Technologies Inc generates 2093% more annual revenue ($5.68B vs $258.90M). KEYS leads profitability with a 17.0% profit margin vs -15.5%. KEYS earns a higher WallStSmart Score of 64/100 (C+).

KEYS

Buy

64

out of 100

Grade: C+

Growth: 6.7Profit: 7.5Value: 2.7Quality: 6.5
Piotroski: 3/9Altman Z: 2.61

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

KEYSSignificantly Overvalued (-52.7%)

Margin of Safety

-52.7%

Fair Value

$155.85

Current Price

$349.91

$194.06 premium

UndervaluedFair: $155.85Overvalued
ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

KEYS3 strengths · Avg: 9.0/10
EPS GrowthGrowth
68.0%10/10

Earnings expanding 68.0% YoY

Market CapQuality
$57.53B9/10

Large-cap with strong market position

Revenue GrowthGrowth
23.3%8/10

Revenue surging 23.3% year-over-year

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

KEYS4 concerns · Avg: 3.3/10
PEG RatioValuation
1.974/10

Expensive relative to growth rate

Price/BookValuation
9.7x4/10

Trading at 9.7x book value

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

P/E RatioValuation
59.2x2/10

Premium valuation, high expectations priced in

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : KEYS

The strongest argument for KEYS centers on EPS Growth, Market Cap, Revenue Growth. Profitability is solid with margins at 17.0% and operating margin at 16.3%. Revenue growth of 23.3% demonstrates continued momentum.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : KEYS

The primary concerns for KEYS are PEG Ratio, Price/Book, Piotroski F-Score. A P/E of 59.2x leaves little room for execution misses.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

KEYS profiles as a growth stock while ZEPP is a hypergrowth play — different risk/reward profiles.

ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor SCIENTIFIC & TECHNICAL INSTRUMENTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

KEYS scores higher overall (64/100 vs 41/100), backed by strong 17.0% margins and 23.3% revenue growth. ZEPP offers better value entry with a 48.6% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Keysight Technologies Inc

TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA

Keysight Technologies, or Keysight, is an American company that manufactures electronics test and measurement equipment and software.

Visit Website →

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?